comparemela.com

Latest Breaking News On - Issue size - Page 7 : comparemela.com

Infollion Research Services' IPO opens on 29th May 2023

Infollion Research Services' IPO opens on 29th May 2023
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

India
Mumbai
Maharashtra
Ashok-holani
Gaurav-munjal
Infollion-research-services
Holani-consultants-private
Infollion-research-service
Issue-is-holani-consultants-private
Issue-is-link-intime-india-private
Infollion-research-services-limited
Human-cloud

Infollion Research Services' IPO opens on 29th May 2023

Business News | Krishca Strapping Solutions' IPO Opens on 16th May 2023

Get latest articles and stories on Business at LatestLY. Krishca Strapping Solutions Limited, one of the leading manufacturer and wholesaler of high tensile steel straps, strapping seals and strapping tools has announced its plans to go public with an Initial Public Offering (IPO) on May 16th, 2023. The company is aiming to raise Rs 17.93 crore through this IPO, with shares set to be listed on the NSE EMERGE platform. Business News | Krishca Strapping Solutions IPO Opens on 16th May 2023.

Mumbai
Maharashtra
India
Anand-srivastava
Lenin-krishnamoorthy-balamanikandan
Issue-is-purva-sharegistry-india-private
Share-india-capital-services-private
Krishca-strapping-solutions
Issue-is-share-india-capital-services-private
Krishca-strapping-solutions-limited
Initial-public-offering
Anchor-investor-bidding

Macquarie gives 'outperform' rating to Mankind Pharma, sees 30% upside

Brokerage firm Macquarie Research has given Mankind Pharma Ltd an outperform rating with a target price of Rs 1400 per share, indicating a potential upside of 29.6% from its issue price of Rs 1068 per share.

India
Mankind-pharma-ltd
Macquarie-research
Pfizer
Novartis
Mankind-pharma
India-pharma-market
Markets-news
Uzzing-stocks
Equity-markets
Mankind-pharma

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.